Search - Prime Therapeutics
Navigate to
-
Academy of Managed Care Pharmacy (AMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
BioPharma Dive: There are no drugs specifically for polycystic ovary syndrome, a chronic condition that can cause infertility. One study is testing whether Wegovy might be beneficial.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...
-
Cover for 2023 January Quarterly Pipeline A view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_jan?fr=sODMzODc3NDc1ODQ About...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Cover for 2023 April Quarterly Pipeline A view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_apr?fr=xKAE9_zU1NQ About Prime...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Cover for 2023 July Quarterly Pipeline a view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_jul?fr=sMjFiMTc3NDc1ODQ About...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Cover for 2023 October Quarterly Pipeline A view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_oct?fr=sMTIyZTc3NDc1ODQ About...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Publications Clinical Highlights: April 2025 Your monthly source for drug information highlights. April 29, 2025 Trending topics Results from the double-blind, placebo-controlled SOUL trial...
-
PUBLICATIONS FDA Decisions Expected Drug pipeline for December 2024 November 15, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...
-
Lassen, chief clinical officer at Prime Therapeutics/Magellan Rx, shares insights on GLP-1 weight-loss drugs and evidence-based approaches to providing the kind of care we’d want for our loved ones.
PA Sub-Categories: GLP-1 Prime Article: Perspectives